Navigation Links
Particle Sciences Further Expands Combination Product Development Capabilities
Date:6/16/2009

BETHLEHEM, Pa., June 16 /PRNewswire/ -- Particle Sciences Inc., a leading service provider for the development of thermoplastic based Combination Products (drug-eluting devices), has further expanded their development and pilot production capabilities with the addition of a Leistritz ZSE-18mm twin screw compounding extruder. This expands a compounding, extrusion, pelletization and injection molding line that is suitable for the preparation of high quality Combination Products to support clients' development programs. "With the addition of the Leistritz compounding extruder to our Class 10,000 clean room, Particles Sciences offers development services for thermoplastic Combination Products. We can support such development efforts from concept to clinic," says Dr. Andrew Loxley, Director of New Technologies. Dr. Robert W. Lee, (VP of Pharmaceutical Development) adds, "We are very pleased with the interest we have generated so far. We are now actively working on three Combination Products from different clients, all based on small molecule release from thermoplastics."

Particle Sciences is an integrated provider of drug development services. Particle Sciences focuses on emulsions, gels, particulates and drug/device combination products with additional specialized capabilities in topical and mucosal drug delivery. Through a full range of formulation, analytic, and manufacturing services, Particle Sciences provides pharmaceutical companies with a complete and seamless development solution that minimizes the time and risk between discovery and the clinic. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. Visit www.particlesciences.com, email info@particlesciences.com or contact us at (610) 861-4701 for information.

    Contact:
    Maureen Cochran
    mcochran@particlesciences.com
    +1-610-861-4701


'/>"/>
SOURCE Particle Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. UCF researchers nanoparticles could someday lead to end of chemotherapy
2. Novel approach estimates nanoparticles in environment
3. Compact cancer-therapy particle-delivery system patented
4. Nanoparticles May Help Attack Cancer More Directly
5. Stanford researchers harness nanoparticles to track cancer-cell changes
6. Nanoparticle smart bomb targets drug delivery to cancer cells
7. Team Designs Gold Nanoparticles to Deliver Multiple Drugs
8. Gold nanoparticles for controlled drug delivery
9. Nontoxic nanoparticle can deliver and track drugs
10. Nanoparticles trigger cell death?
11. Consumers Union Urges FDA to Conduct Full Scale Safety Review of Nanoparticles in Sunscreen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... Farmingdale, NY (PRWEB) , ... May 26, 2016 ... ... and Hereditary Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on ... free to the public. , Dr. Maisel, founder of Retina Group of ...
(Date:5/26/2016)... ... ... In an effort to provide hair restoration information to the widest possible audience, Dr. Parsa ... not use the app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making ... , Dr. Mohebi says, “The positive response to the Snapchat videos we started last month ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/26/2016)... May 26, 2016 Since its ... into an essential life science tool for conducting genetic ... BCC Research reveals in its new report that the ... phase, one powered by a range of new applications ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
Breaking Medicine Technology: